Cabot Market Letter Named Best Financial-Advisory Newsletter

FOR IMMEDIATE RELEASE
June 2, 2009

WASHINGTON, June 2, 2009—Leading investment newsletter publisher Cabot Heritage Corp. announced that its flagship publication, Cabot Market Letter, was recognized as the Best Financial-Advisory Newsletter 2009 by the Specialized Information Publishers Foundation (SIPF). SIPF represents thousands of newsletters and specialized publications, and the Foundation's awards draw hundreds of entries annually from exceptional journalists worldwide.

Established in 1970, Cabot Market Letter is one of a handful of investment newsletters that have been continually published for more than 30 years. Michael Cintolo, a growth stock and market timing expert, is editor of the Letter. In bestowing this First Place award, the Foundation noted that from the March 2003 market bottom to the March 2009 low, Cabot Market Letter's Model Portfolio gained 94%, while the Nasdaq lost 3.5% and the S&P 500 lost 18%.

Second place was awarded to Motley Fool Stock Adviser, published by The Motley Fool, and third place went to The MoneyLetter, published by MPL Communications.

This is the second consecutive year that a Cabot publication won the SIPF Best Financial Newsletter award. Cabot China & Emerging Markets Report was named the Best Financial Newsletter in 2008.

SIPF is a non-profit foundation affiliated with the Specialized Information Publishers Association, an international trade association dedicated to advancing the interests of for-profit subscription newsletter publishers and specialized-information services. The Foundation promotes specialized-information publishing through outreach to academic and professional institutions, facilitation of research, and recognition of excellence in the field though its annual awards.

About Cabot
Cabot is an independent publisher of eight investment advisories serving more than 150,000 individual and professional investors around the world.

More information on Cabot Market Letter

More Cabot in the News

Cabot Home


More News about Cabot
Cabot Home
Sign up for free Cabot Wealth Advisory e-newsletter


Stock Picks

Loews Corp.

This undervalued stock has strong future earnings growth expectations.

Biogen

Biogen is the market-share leader in treating multiple sclerosis.

Weibo

One of Paul Godwin’s favorite stocks in his Cabot Emerging Markets Investor portfolio.

Cabot Wealth Advisory

Does Alibaba (BABA) Stock Measure Up to Amazon (AMZN)?

By Paul Goodwin on September 23, 2016

Alibaba (BABA) is the Amazon (AMZN) of China. But does BABA stock measure up to AMZN stock? Let’s break it down!Read More >

As Stock Market Trends Change, Invest in these New Leaders

By Michael Cintolo on September 22, 2016

History tells us that all stock market trends change, and if you don’t recognize the leaders of that change early, you risk missing out on the next big winners.Read More >

AMZN Stock vs. FB Stock: Which Is the Better Value Buy?

By J. Royden Ward on September 20, 2016

For the past five years, AMZN stock and FB stock have been two of the market's great growth stories. But could you make the case that either stock is still undervalued? Let’s break it down.Read More >